Introduction
There are many different white matter disorders, both inherited and acquired. Soon after MRI was introduced into medicine in the mid-eighties, it became apparent that MRI was very sensitive with respect to the presence of white matter abnormalities. In the early nineties we were able to demonstrate that MRI also had a high diagnostic specificity 1 . The MRI patterns were strikingly homogeneous among patients with the same disorder and different from patterns seen in other disorders. We developed an MRI pattern recognition system based on these observations 1 . We analyzed and scored MR images of hundreds of patients with a known white matter disorder and integrated the findings into different patterns, specific for a certain disorder or group of disorders 1 
.
Gradually it became apparent that white matter abnormalities of unknown origin constitute a big problem in Neurology, particularly in Child Neurology. In over 50% of the children with significant white matter abnormalities on MRI no specific diagnosis could be established, despite extensive laboratory investigations. Because MRI pattern recognition worked well for the classified leukoencephalopathy, we decided to explore its potential among the children with unclassified leukoencephalopathies 2 . MRS gives important though limited biochemical information on the brain and its constituents. In a few instances it has provided the information that appeared to be essential in the detection of novel encephalopathies. Until now the most important example is found in the disorders characterized by cerebral creatine deficiency. For this reason we decided to also perform MRS in patients with a leukoencephalopathy of unknown origin.
Results and Discussion
The first novel leukoencephalopathy identified on the basis of a characteristic MRI pattern is called "megalencephalic leukoencephalopathie with subcortical cysts" (MLC) 3 . The MRI is characterized by diffusely abnormal, mildly swollen cerebral white matter and relative sparing of central white matter structures including corpus callosum, internal capsule and brain stem. The cerebellar white matter usually has a mildly abnormal signal intensity without swelling. The clinical picture is characterized by macrocephaly within the first year of life. There is a delayed onset of motor deterioration, dominated by cerebellar ataxia. The disease has an autosomal recessive mode of inheritance. Our genetic linkage study resulted in the identification of a gene for the disease: MLC1 4 . The function of the MLC1 protein is still unknown.
Another novel leukoencephalopathy with characteristic MRI findings is variably called "vanishing white matter" (VWM) and "childhood ataxia with central hypomyelination" (CACH) [5] [6] [7] . The MRI is characterized by diffusely abnormal cerebral white matter, which vanishes over time. As a consequence, increasing parts of the cerebral white matter follow CSF in signal intensity on all pulse sequences. It is necessary to use either proton density or FLAIR images to show the CSFlike nature of part of the cerebral white matter. The onset of the clinical disease varies from the neonatal period to adulthood. The clinical picture is characterized by a progressive neurological deterioration usually dominated by cerebellar ataxia. There are additional episodes of rapid and major deterioration provoked by febrile infections and minor head trauma. The disease has an autosomal recessive mode of inheritance. In a genetic linkage study we were able to identify five genes for the disease 8, 9 . Using 1 H-MRS, we identified a patient with a leukoencephalopathy of unknown origin and highly elevated peaks in the polyol and sugar region of the spectrum (3.5-3.9 ppm) 10 . We showed that these peaks are related to D-arabital and ribitol. The same substances were found in high concentrations in body fluids, including urine. Disorders in polyol metabolism have not be described before and are not part of routine metabolic urine screening. We have been able to demonstrate the enzyme and gene defect in this patient 11 . Another newly identified leukoencephalopathy is called "hypomyelination with atrophy of the basal ganglia and cerebellum" (HABC) 12 . The MRI pattern is characterized by hypomyelination and atrophy and disappearance of the putamen and caudate nucleus. Over time there is also atrophy of the cerebellum and a variable atrophy of the cerebral white matter. Clinically, the disease is dominated by extrapyramidal movement abnormali-ties, in addition to spasticity and cerebellar ataxia. The mental deficiency is variable. The disease is slowly progressive over time. All patients are sporadic.
In 2003, we described a novel disorder, called "leukoencephalopathy with brain stem and spinal cord involvement and elevated lactate" (LBSL) 13 . The disease has a childhood onset and is slowly progressive with signs of spasticity, ataxia and dorsal column dysfunction. MRI shows cerebral white matter abnormalities in combination with involvement of specific brain stem structures.
Spinal cord MRI shows involvement of the dorsal columns and lateral corticospinal tracts over their entire extent. In 2007 we found a gene for the disease, DARS2, which encodes mitochondrial aspartyl tRNA synthetase 14 .
Conclusion
MRI and, to a lesser extent, MRS are powerful tools in the study of leukoencephalopathies of unknown origin.
